| Secondary |
| Drug Use For Unknown Indication |
37.7% |
| Hypertension |
7.0% |
| Drug Exposure During Pregnancy |
6.6% |
| Product Used For Unknown Indication |
6.6% |
| Acute Coronary Syndrome |
5.7% |
| Hiv Infection |
4.0% |
| Pain |
4.0% |
| Ill-defined Disorder |
3.7% |
| Atrial Fibrillation |
3.5% |
| Urinary Tract Infection |
2.6% |
| Multiple Myeloma |
2.4% |
| Myocardial Infarction |
2.2% |
| Nasopharyngitis |
2.0% |
| Atrial Flutter |
1.8% |
| Hypothyroidism |
1.8% |
| Nausea |
1.8% |
| Pericarditis |
1.8% |
| Sedation |
1.8% |
| Epilepsy |
1.5% |
| Foetal Exposure During Pregnancy |
1.5% |
|
| Thrombocytopenia |
10.0% |
| Drug Exposure During Pregnancy |
7.5% |
| Renal Failure Acute |
7.5% |
| Ventricular Fibrillation |
7.5% |
| Vomiting |
7.5% |
| Hydrocephalus |
6.3% |
| Oesophageal Haemorrhage |
6.3% |
| Subdural Haematoma |
5.0% |
| Toxic Epidermal Necrolysis |
5.0% |
| Urethral Valves |
5.0% |
| Anaemia |
3.8% |
| Hypospadias |
3.8% |
| Melaena |
3.8% |
| Pallor |
3.8% |
| Vascular Complication Associated With Device |
3.8% |
| Visual Acuity Reduced |
3.8% |
| Aortic Intramural Haematoma |
2.5% |
| Cytolytic Hepatitis |
2.5% |
| Dyspnoea |
2.5% |
| Epistaxis |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.0% |
| Hypertension |
10.0% |
| Product Used For Unknown Indication |
8.1% |
| Multiple Myeloma |
7.3% |
| Prophylaxis |
7.2% |
| Thrombosis Prophylaxis |
5.4% |
| Pain |
4.9% |
| Ill-defined Disorder |
3.4% |
| Coronary Artery Disease |
2.7% |
| Infection |
2.2% |
| Liver Transplant |
2.1% |
| Type 2 Diabetes Mellitus |
2.0% |
| Unevaluable Event |
2.0% |
| Hiv Infection |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Dyslipidaemia |
1.5% |
| Anxiety |
1.4% |
| Bone Pain |
1.4% |
| Nausea |
1.4% |
| Sedation |
1.4% |
|
| Renal Failure |
11.4% |
| Weight Decreased |
7.8% |
| Thrombocytopenia |
6.8% |
| Agranulocytosis |
6.4% |
| Myocardial Infarction |
5.9% |
| Vomiting |
5.9% |
| Pyrexia |
5.5% |
| Ventricular Fibrillation |
5.5% |
| Neutropenia |
5.0% |
| Renal Failure Acute |
5.0% |
| Septic Shock |
5.0% |
| Rectal Haemorrhage |
4.1% |
| Toxic Skin Eruption |
4.1% |
| Sepsis |
3.7% |
| Pruritus |
3.2% |
| Vertigo |
3.2% |
| Weight Increased |
3.2% |
| Cytolytic Hepatitis |
2.7% |
| Eosinophilia |
2.7% |
| General Physical Health Deterioration |
2.7% |
|
| Interacting |
| Atrial Fibrillation |
21.2% |
| Hypertension |
12.1% |
| Diabetes Mellitus |
9.1% |
| Pain |
9.1% |
| Acute Coronary Syndrome |
6.1% |
| Hypertensive Cardiomyopathy |
6.1% |
| Myocardial Ischaemia |
6.1% |
| Pain In Extremity |
6.1% |
| Pyrexia |
6.1% |
| Arthropathy |
3.0% |
| Benign Neoplasm Of Prostate |
3.0% |
| Drug Use For Unknown Indication |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Hypothyroidism |
3.0% |
| Myocardial Infarction |
3.0% |
|
| Muscle Haemorrhage |
20.0% |
| Stress Cardiomyopathy |
20.0% |
| Drug Interaction |
10.0% |
| Intestinal Haemorrhage |
10.0% |
| Lymphadenitis |
10.0% |
| Rectal Haemorrhage |
10.0% |
| Renal Failure Acute |
10.0% |
| Vomiting |
10.0% |
|
